American Express stock dips today as Fed minutes weigh on financials; AXP earnings date in focus

American Express stock dips today as Fed minutes weigh on financials; AXP earnings date in focus

NEW YORK, December 30, 2025, 15:31 ET — Regular session Key points: American Express Co (AXP) shares fell 0.3% to $374.12 in late afternoon trading on Tuesday, after moving between $373 and $377 in the session. Visa and Mastercard were also down about 0.2% and 0.1%, respectively. The move matters because American Express is one of the higher-priced components of the Dow, a price-weighted index that gives bigger sway to costlier stocks. With year-end liquidity thin, small swings can ripple through benchmarks and sector ETFs more quickly. Investors are also treating AXP as a read-through on rate expectations and consumer
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

NEW YORK, December 30, 2025, 15:25 ET — Regular session Scholar Rock Holding Corp (SRRK) slid 3.2% to $43.76 in afternoon trading on Tuesday after opening at $45.18. The stock traded between $45.95 and $43.74. The move matters because Scholar Rock’s near-term valuation still hinges on regulatory timing for apitegromab, its lead drug candidate. he company said in an October update that the FDA classified a third-party manufacturing site in Bloomington, Indiana (formerly Catalent Indiana LLC, now fully owned and operated by Novo Nordisk) as “official action indicated” and that it requested a Type A meeting to discuss resubmitting its
30 December 2025
Progressive stock ticks higher today after SEC filing flags 87,755-share gift; what investors watch next

Progressive stock ticks higher today after SEC filing flags 87,755-share gift; what investors watch next

NEW YORK, December 30, 2025, 15:29 ET — Regular session Shares of The Progressive Corporation (NYSE:PGR) were up about 0.7% at $230 on Tuesday afternoon after a regulatory filing disclosed a large gift of stock by a company director. The stock traded between $227.53 and $230.03, with about 1.0 million shares changing hands. The disclosure lands in a year-end market where liquidity is thin and small shifts in positioning can show up quickly in defensive financials such as insurers. Progressive is also heading into a key stretch for the personal auto insurance group, where investors tend to focus on whether
30 December 2025
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

NEW YORK, December 30, 2025, 15:32 ET — Regular session GRAIL Inc shares were down 3.3% at $84.95 in afternoon trading on Tuesday, after earlier touching $84.77. The early-cancer detection company is trying to turn Galleri — a multi-cancer early detection (MCED) blood test that screens for signals across many cancers from a single draw — into a mainstream part of care. In its most recent quarterly update, Grail said U.S. Galleri revenue rose 28% year-on-year to $32.6 million and test volumes increased 39%, while it anticipated completing a U.S. premarket approval filing in the first quarter of 2026. GRAIL
McDonald’s stock today: MCD edges down as Fed minutes, year-end trade keep investors cautious

McDonald’s stock today: MCD edges down as Fed minutes, year-end trade keep investors cautious

NEW YORK, December 30, 2025, 15:29 ET — Regular session McDonald’s Corp shares edged lower on Tuesday, trading at $308.37, down 0.05% in late-afternoon dealings. The timing matters. With two sessions left in the year, trading volumes tend to thin out, and small shifts in positioning can move stocks more than usual, especially in defensive names investors use to park cash. Portfolio managers also use the final week of December to trim big winners and rebalance exposure for January. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at
Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

Bloom Energy stock slips today as Clear Street lifts target but keeps Hold in thin year-end trade

NEW YORK, December 30, 2025, 15:25 ET — Regular session Bloom Energy Corp shares fell on Tuesday as year-end positioning and a soft tape for growth stocks kept pressure on the fuel-cell maker. The stock was down 1.7% at $86.93 in afternoon trading. The move matters because trading volumes have stayed light in the holiday-truncated week, which can amplify intraday swings in volatile names. U.S. stocks were subdued in choppy trade, with gains in communication services capped by declines in technology and financials, Reuters reported. Reuters Analysts are also recalibrating their assumptions for companies tied to data-center power demand, a
30 December 2025
Upwork stock drops 3% today as UPWK slips below $20 with earnings ahead

Upwork stock drops 3% today as UPWK slips below $20 with earnings ahead

NEW YORK, December 30, 2025, 15:28 ET — Regular session Upwork Inc shares were last down 3.4% at $19.60 on Tuesday, after dipping as low as $19.60 in the session. The stock, valued at about $2.46 billion, was sliding even as the S&P 500 and Nasdaq-100 proxies were only modestly lower. The move matters because Upwork has been trading as a profitability-and-execution story, leaving the stock prone to sharp swings when investors rotate away from smaller growth names. A fall below the $20 level also puts a spotlight on near-term technical support, with traders watching whether the stock can reclaim
American Airlines stock edges up today as Chicago O’Hare expansion and storm fallout stay in focus

American Airlines stock edges up today as Chicago O’Hare expansion and storm fallout stay in focus

NEW YORK, December 30, 2025, 15:22 ET — Regular session American Airlines Group Inc shares were up about 0.6% at $15.24 in afternoon trading on Tuesday. The move matters now because U.S. carriers are still working through weather-driven disruption during a peak holiday travel stretch, while also selling spring schedules that can shape early-2026 revenue and costs. Chicago is a key battleground. For American, the O’Hare hub feeds higher-yielding connections and international flying, and changes there can quickly show up in load factors and pricing. American on Monday said it will add 100 peak daily departures from Chicago O’Hare in
Hut 8 stock today: Why HUT is down even as bitcoin edges higher

Hut 8 stock today: Why HUT is down even as bitcoin edges higher

NEW YORK, December 30, 2025, 15:21 ET — Regular session Hut 8 Corp (HUT) shares fell 3.1% to $47.31 in afternoon trading on Tuesday, after moving between $47.18 and $49.26 earlier in the session. About 2.26 million shares had traded. The pullback matters because Hut 8 sits at the intersection of two fast-moving themes: bitcoin-linked equities and the market’s scramble for data centers to run artificial intelligence (AI) workloads. That mix has made the stock prone to sharp, sentiment-driven swings. The broader backdrop has been choppy. U.S. stocks were subdued on Tuesday and trading volumes remained thin in the holiday-truncated
Coca-Cola stock slips as Fed minutes hit thin year-end trade; KO investors eye next catalyst

Coca-Cola stock slips as Fed minutes hit thin year-end trade; KO investors eye next catalyst

NEW YORK, December 30, 2025, 3:25 PM ET — Regular session Coca-Cola shares edged lower on Tuesday, holding near $70 as investors kept risk-taking limited in thin, year-end trading. The quiet tape matters because Coca-Cola is a classic defensive stock. When markets get choppy, investors often rotate into consumer staples — everyday products like food and beverages — for steadier demand and cash returns. It also matters now because interest-rate expectations are back in focus. Dividend-paying shares can lose relative appeal when bond yields rise, since investors can earn more in cash-like alternatives without taking equity risk. Coca-Cola was down
30 December 2025
Verizon stock today: VZ edges up as DOJ DEI probe headline hangs over telecom ahead of Jan. 30 earnings

Verizon stock today: VZ edges up as DOJ DEI probe headline hangs over telecom ahead of Jan. 30 earnings

NEW YORK, December 30, 2025, 15:17 ET — Regular session Verizon Communications Inc shares were up 0.5% at $40.69 in afternoon trading on Tuesday, bucking a mostly flat U.S. market as investors digested new regulatory scrutiny and looked ahead to the carrier’s next earnings update. Reuters The latest headline matters because legal and compliance risk can move quickly for large government contractors, and telecoms are already grappling with intense competition and heavy capital spending. Any shift in policy pressure can influence costs, disclosures and management attention. Reuters It also lands during year-end, low-liquidity trading, when relatively small flows can push
30 December 2025
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

NEW YORK, December 30, 2025, 15:14 ET — Regular session Shares of TIC Solutions, Inc. (TIC) fell about 3.5% to $10.02 in afternoon trading on Tuesday, underperforming a largely steady U.S. equity market. The stock last closed at $10.38. The decline came in holiday-thin trade as investors recalibrated rate expectations after the Federal Reserve’s December-meeting minutes hit the tape. “At the end of the day, solid corporate profits can make up for a lot of sins,” said Ryan Detrick, chief market strategist at Carson Group. Reuters The slide matters for TIC because investors have been focused on execution rather than
Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

NEW YORK, December 30, 2025, 15:20 ET — Regular session Applied Materials, Inc. (AMAT.O) shares slipped on Tuesday, with investors weighing fresh signs of tougher competition in China for semiconductor equipment makers. The stock was down 1.1% at $260.27 in mid-afternoon New York trade. The stock drew attention after Reuters reported China is requiring chipmakers seeking approval to build or expand fabs to use at least 50% domestically made equipment when adding new capacity. The measure is not publicly documented and is enforced through procurement tenders, people familiar with the matter told Reuters, and authorities can relax the threshold where
Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

NEW YORK, December 30, 2025, 15:16 ET — Regular session Travere Therapeutics Inc shares were down about 3.8% at $37.39 on Tuesday afternoon, extending losses after recent insider-trading disclosures. The stock traded between $37.27 and $39.20, with about 893,000 shares changing hands. (TVTX quote) The selling matters because it lands just weeks before a major regulatory milestone for the rare-disease drugmaker. Traders often react to clusters of insider sales — even when they are planned — as they reassess near-term positioning. Travere, based in San Diego, markets Filspari for a kidney disease called IgA nephropathy, and is seeking an expansion
30 December 2025
Qualcomm stock edges up as Fed minutes hit; QCOM eyes Feb. 4 earnings call

Qualcomm stock edges up as Fed minutes hit; QCOM eyes Feb. 4 earnings call

NEW YORK, December 30, 2025, 15:14 ET — Regular session Qualcomm (QCOM.O) shares were up about 0.2% at $173.75 in afternoon trading on Tuesday, hovering near Monday’s close as markets digested new details on the U.S. interest-rate outlook. That matters for Qualcomm and other semiconductor names because investors often value them like “growth” stocks, whose prices can swing when bond yields move. In year-end trading, the rate narrative can outweigh company-specific headlines. Minutes from the Federal Reserve’s Dec. 9-10 meeting — the detailed account of policymakers’ debate — showed officials split even after approving a quarter-point, or 0.25 percentage point,
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

NEW YORK, December 30, 2025, 2:30 PM ET — Regular session Shares of Catalyst Pharmaceuticals, Inc. fell 3.0% to $23.33 in afternoon trading on Tuesday. The stock has traded between $23.30 and $24.10 so far in the session. The drop matters because trading can get choppy in the final days of the year, when fewer investors are active and price moves can be exaggerated. Mid-cap healthcare names often swing more than the major indexes in that setting. Catalyst fell 1.2% on Monday to close at $24.06, according to MarketWatch data, and it remains well below its June 9 52-week high
Seagate stock edges lower as year-end AI trade cools; STX turns to January earnings

Seagate stock edges lower as year-end AI trade cools; STX turns to January earnings

NEW YORK, December 30, 2025, 15:01 ET — Regular session Seagate Technology Holdings plc shares were down 0.2% at $280.77 in afternoon trading on Tuesday, drifting after a year when the hard-drive maker became a marquee bet on AI-linked data-center spending. The stock has traded between $280.19 and $284.09 so far in the session, with about 694,000 shares changing hands. The soft patch matters because Seagate has been one of 2025’s standout infrastructure winners, leaving the stock more sensitive to shifts in sentiment around cloud budgets, storage pricing and the durability of the AI spending cycle. Investors are also closing
Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

NEW YORK, December 30, 2025, 14:30 ET — Regular session Shares of Kymera Therapeutics fell about 3% to $77.94 in afternoon trading on Tuesday, lagging a broader biotech dip. The SPDR S&P Biotech ETF was down about 1.4%, while the iShares Nasdaq Biotechnology ETF slipped about 1.1%. The pullback matters because Kymera has been one of the sector’s higher-volatility names this month, after a surge tied to new clinical data and a subsequent stock sale that increased its share count. With most of its next major readouts still far off, investors have been quick to reprice the stock around financing
Nebius stock slips today after CEO files to sell shares — what traders are watching next

Nebius stock slips today after CEO files to sell shares — what traders are watching next

NEW YORK, December 30, 2025, 15:09 ET — Regular session Nebius Group N.V. shares slipped on Tuesday after a regulatory filing showed chief executive Arkady Volozh plans to sell a small block of stock around year-end. SEC+1 The disclosure matters because Nebius has become a closely watched AI infrastructure name, where investors have been quick to react to any potential increase in share supply. Year-end trading can amplify moves, as fewer shares changing hands can push prices around. SEC Form 144 is the SEC notice insiders file when they intend to sell “control” securities, typically ahead of the actual transactions.
30 December 2025
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

NEW YORK, December 30, 2025, 3:07 PM ET — Regular session Shares of Almonty Industries Inc fell about 3.9% to $8.90 in afternoon trading on Tuesday after giving up an early rise, with the stock swinging between $8.90 and $9.39. The pullback comes as investors focus on tungsten, a hard metal used in munitions, industrial tooling and electronics, at a moment when governments are pushing to secure strategic supply chains. A CBS News report published on Monday said Chief Executive Lewis Black met U.S. officials, including at the White House, before touring Almonty’s Sangdong mine in South Korea and signing

Stock Market Today

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop